All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Solid Organ Transplantation Hub is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View solid organ transplantation content recommended for you
Stay up to date with the latest developments in solid organ transplantation, with the SOT Hub’s summaries of key presentations from the 31st International Congress of The Transplantation Society (TTS), September 20–23, 2026, Sydney, AU.
 (1).jpeg)
During the 31st International Congress of TTS, Lim et al. presented results from a retrospective analysis evaluating the impact of advanced perfusion strategies in donation after circulatory death (DCD) and donation after brain death (DBD) liver transplantation on graft and patient outcomes.
During the 31st International Congress of The Transplantation Society (TTS), Kwon et al. presented results from a prospective study evaluating dd-cfDNA as a predictor of allograft functional decline beyond standard Banff histology in kidney transplant recipients.
.jpeg)
During the 31st International Congress of The Transplantation Society (TTS), Robinson et al. presented results from a retrospective study evaluating the association between distinct CLAD phenotypes and HLA–KIR interactions in lung transplant recipients.
During the 31st International Congress of TTS, Adams et al. presented results from the phase II BESTOW trial and the BESTOW EXTENSION, evaluating tegoprubart vs tacrolimus in patients undergoing kidney transplantation.
During the 31st International Congress of TTS, Mayer et al. presented results from an open-label extension of a phase II trial evaluating prolonged CD38 targeting with felzartamab in kidney transplant recipients with AMR.
During the 31st International Congress of TTS, Basic-Jukic et al. presented results a single-center case series evaluating ECP for biopsy-proven AMR in kidney transplant recipients at high risk of infection.
During the 31st International Congress of TTS, Watagodakumbura et al. presented results from a retrospective cohort study evaluating the clinical burden of CMV infection and the impact of extended valganciclovir prophylaxis in CMV-seronegative lung transplant recipients.
During the 31st International Congress of TTS, Kamar et al. presented interim results from the ARISE study, evaluating the real-world effectiveness and safety of maribavir in SOT recipients with R/R CMV or intolerance to anti-CMV therapy.
During the 31st International Congress of TTS, Daamen et al. presented results from the REVOLUTION trial, comparing immediate-release vs once-daily extended-release tacrolimus in de novo lung transplant recipients.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.
Your opinion matters
Which topic, relating to ECP, do you think would be the most valuable educational content for the SOT Hub?
